Aug 7, 2018 Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update Prothena Reports Second Quarter 2018 Financial Results and Provides R&D Update“We are developing a broad and novel pipeline targeting devastating neurological diseases and steadily advancing both our proprietary programs as ... read morePublished on 2018-08-07